Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and changing regulatory requirements by expanding its portfolio of TPO-free light-curable materials.
Preemptive Compliance and Long-Term Readiness
In anticipation of the European Union legislative changes on Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and in response to growing consumer concerns around the world, Dymax is expanding our portfolio of TPO-free formulations designed to meet evolving safety standards and support long-term product design and planning.
The available TPO-free products have been rigorously tested to deliver the performance and quality characteristics expected of all Dymax chemistries. For medical device applications, adhesives meet biocompatibility standards, including ISO 10993-5 cytotoxicity and others as appropriate, helping support internal validation or documentation requirements. Additionally, manufacturers who want to integrate the formulations into existing production environments can seek assistance from Dymax technical service specialists who can help customers move confidently through validation processes with current applications or new product development efforts.
"Our commitment to monitoring and assessing the needs of the marketplace and developing innovative and effective solutions drives us to stay ahead of the marketplace," said Michael Ford, Head of Business Development at Dymax. "By enabling access to our expanded portfolio of TPO-free products early and continuing to evolve our product lines where needed, we are giving our customers the confidence to continue using our materials while meeting evolving global standards and end-user needs."
Supporting Product Transitions
Recognizing that any formulation change can raise questions, Dymax provides technical and regulatory support to help customers assess and adopt TPO-free options, including:
Customers are encouraged to contact Dymax technical advisors to answer questions on process and design changes and for support in evaluating solutions that meet immediate performance needs and longer-term planning goals.
Preemptive Compliance and Long-Term Readiness
In anticipation of the European Union legislative changes on Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and in response to growing consumer concerns around the world, Dymax is expanding our portfolio of TPO-free formulations designed to meet evolving safety standards and support long-term product design and planning.
The available TPO-free products have been rigorously tested to deliver the performance and quality characteristics expected of all Dymax chemistries. For medical device applications, adhesives meet biocompatibility standards, including ISO 10993-5 cytotoxicity and others as appropriate, helping support internal validation or documentation requirements. Additionally, manufacturers who want to integrate the formulations into existing production environments can seek assistance from Dymax technical service specialists who can help customers move confidently through validation processes with current applications or new product development efforts.
"Our commitment to monitoring and assessing the needs of the marketplace and developing innovative and effective solutions drives us to stay ahead of the marketplace," said Michael Ford, Head of Business Development at Dymax. "By enabling access to our expanded portfolio of TPO-free products early and continuing to evolve our product lines where needed, we are giving our customers the confidence to continue using our materials while meeting evolving global standards and end-user needs."
Supporting Product Transitions
Recognizing that any formulation change can raise questions, Dymax provides technical and regulatory support to help customers assess and adopt TPO-free options, including:
- Current application product review to determine potential TPO-containing product use
- Product Data Sheets for material property review prior to in-house validation
- Application engineering guidance to evaluate any required process adjustments
- Access to regulatory teams for questions about global compliance requirements
Customers are encouraged to contact Dymax technical advisors to answer questions on process and design changes and for support in evaluating solutions that meet immediate performance needs and longer-term planning goals.
